These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


417 related items for PubMed ID: 3900581

  • 21. A rat hybridoma model of Heymann nephritis: production of a monoclonal anti GP330 from a nephritic rat.
    Behar M, Katz A, Silverman M.
    Clin Invest Med; 1990 Oct; 13(5):264-70. PubMed ID: 2276221
    [Abstract] [Full Text] [Related]

  • 22. Pathogenesis of passive Heymann glomerulonephritis: chlorpromazine inhibits antibody-mediated redistribution of cell surface antigens and prevents development of the disease.
    Camussi G, Noble B, Van Liew J, Brentjens JR, Andres G.
    J Immunol; 1986 Mar 15; 136(6):2127-35. PubMed ID: 3485141
    [Abstract] [Full Text] [Related]

  • 23. Formation of subepithelial dense deposits in rats induced by a monoclonal antibody against the glomerular cell surface antigen.
    Nishikawa K, Fukatsu A, Tamai H, Suzuki N, Ito Y, Sakamoto N, Matsuo S.
    Clin Exp Immunol; 1991 Jan 15; 83(1):143-8. PubMed ID: 1988221
    [Abstract] [Full Text] [Related]

  • 24. Nephritogenic antibodies against kidney brush border glycoproteins in rabbits injected with Freund's adjuvant.
    Miettinen A.
    Lab Invest; 1982 Jul 15; 47(1):67-75. PubMed ID: 7087399
    [Abstract] [Full Text] [Related]

  • 25. Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution.
    Chatelet F, Brianti E, Ronco P, Roland J, Verroust P.
    Am J Pathol; 1986 Mar 15; 122(3):512-9. PubMed ID: 3754090
    [Abstract] [Full Text] [Related]

  • 26. Heymann nephritis induced by kidney brush border glycoproteins.
    Miettinen A, Törnroth T, Tikkanen I, Virtanen I, Linder E.
    Lab Invest; 1980 Dec 15; 43(6):547-55. PubMed ID: 7442131
    [Abstract] [Full Text] [Related]

  • 27. Involvement of an antigen distinct from the Heymann antigen in membranous glomerulonephritis in the mouse.
    Assmann KJ, Ronco P, Tangelder MM, Lange WP, Verroust P, Koene RA.
    Lab Invest; 1989 Jan 15; 60(1):138-46. PubMed ID: 2642986
    [Abstract] [Full Text] [Related]

  • 28. Progressive passive Heymann nephritis in the rat.
    Barabas AZ, Boyd N, Cornish J, Lannigan R.
    Lab Invest; 1982 Oct 15; 47(4):400-5. PubMed ID: 6214666
    [Abstract] [Full Text] [Related]

  • 29. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border.
    Kerjaschki D, Farquhar MG.
    Proc Natl Acad Sci U S A; 1982 Sep 15; 79(18):5557-61. PubMed ID: 6752952
    [Abstract] [Full Text] [Related]

  • 30. [Cellular pathology of Heyman nephritis: monoclonal antibodies against the pathogenic antigen Gp 330].
    Kerjaschki D.
    Wien Klin Wochenschr; 1985 Jul 19; 97(14):581-8. PubMed ID: 3901534
    [Abstract] [Full Text] [Related]

  • 31. Antibodies to purified renal tubular epithelial antigens contain activity against laminin, fibronectin, and type IV collagen.
    Hogendoorn PC, Bruijn JA, vd Broek LJ, De Heer E, Foidart JM, Hoedemaeker PJ, Fleuren GJ.
    Lab Invest; 1988 Mar 19; 58(3):278-86. PubMed ID: 3279261
    [Abstract] [Full Text] [Related]

  • 32. Comparison of antigenic targets involved in antibody-mediated membranous glomerulonephritis in the mouse and rat.
    Assmann KJ, Ronco P, Tangelder MM, Lange WP, Verroust P, Koene RA.
    Am J Pathol; 1985 Oct 19; 121(1):112-22. PubMed ID: 2413764
    [Abstract] [Full Text] [Related]

  • 33. Antibody-mediated proliferation of proximal tubule cells requires cross-linking of antigenic determinants.
    Brodkin M, Noble B.
    Clin Exp Immunol; 1988 May 19; 72(2):315-20. PubMed ID: 2457465
    [Abstract] [Full Text] [Related]

  • 34. Biochemical investigation of the pathogenesis of Heymann nephritis.
    Behar M, Katz A, Silverman M.
    Kidney Int; 1986 Jul 19; 30(1):9-15. PubMed ID: 3747348
    [Abstract] [Full Text] [Related]

  • 35. Severe glomerular epithelial cell damage does not prevent passive Heyman nephritis in rats.
    Bertani T, Remuzzi G, Poggi A, Delaini F, Sacchi G, Morassi L, Verroust P, Mecca G, Donati MB.
    Clin Exp Immunol; 1983 Jan 19; 51(1):38-44. PubMed ID: 6339125
    [Abstract] [Full Text] [Related]

  • 36. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T, Pluss R, Lacher J, Boedecker E, Guggenheim S, Hammond W, McIntosh R.
    Q J Med; 1975 Oct 19; 44(176):523-41. PubMed ID: 53850
    [Abstract] [Full Text] [Related]

  • 37. Circulatory antigen of Heymann nephritis. II. Isolation of a 70,000 MW antigen from normal rat serum which cross-reacts with Heymann nephritis antigen.
    Singh AK, Schwartz MM.
    Immunology; 1986 Nov 19; 59(3):451-8. PubMed ID: 3539772
    [Abstract] [Full Text] [Related]

  • 38. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M, Schulze M, Exner M, Kerjaschki D.
    Am J Pathol; 1994 Apr 19; 144(4):807-19. PubMed ID: 8160779
    [Abstract] [Full Text] [Related]

  • 39. Monoclonal autoantibodies in Heymann nephritis.
    Kimura S, Sakurai A, Morioka T, Matsui K, Nakamura T, Yakata M, Oite T, Shimizu F.
    Clin Exp Immunol; 1986 Jul 19; 65(1):28-33. PubMed ID: 3539425
    [Abstract] [Full Text] [Related]

  • 40. Kidney immunopathology and pathophysiology in rats immunized with proximal tubule cell brush border or basolateral membrane vesicles.
    Haddad A, Goldinger JM, Van Liew JB, Noble B.
    Immunol Invest; 1987 May 19; 16(3):213-25. PubMed ID: 3311982
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.